Product Description
Afatinib Dimaleate 40mg Tablets: What the Published Guidance Says
Cytotoxic and targeted agents spanning the taxane, antifolate and EGFR-tyrosine-kinase-inhibitor classes, supplied with the analytical and stability documentation oncology procurement requires.
Buyers usually settle three things before ordering Afatinib Dimaleate 40mg Tablets: the pharmacopoeial monograph, the pack configuration, and the documents the destination authority will ask for.
- EGFR tyrosine-kinase inhibitors and their toxicity profile In its review of non-small cell lung cancer, the WHO Expert Committee recorded that EGFR tyrosine-kinase inhibitors are generally well tolerated, with diarrhoea occurring in more than 60% of patients treated, characteristic dermatological toxicity and rash across the class, and potential hepatic toxicity. Rare but severe gastrointestinal toxicity, including perforation, was noted particularly with erlotinib. WHO EML Expert Committee — Non-small cell lung cancer review
- 2025 extended access to checkpoint inhibitors Pembrolizumab was added to the Model List as first-line monotherapy for metastatic cervical cancer, metastatic colorectal cancer and metastatic non-small cell lung cancer, with atezolizumab and cemiplimab as therapeutic alternatives for the lung indication. WHO — Essential medicines list updated to include key cancer and diabetes treatments (5 Sep 2025)
- WHO applies a hard benefit threshold to cancer listings When the September 2025 revision was prepared, WHO evaluated 25 cancer medicines across seven applications and states that only therapies proven to prolong life by at least four to six months are included on the Model List. Listing is therefore a deliberately narrow signal, not a catalogue of everything approved. WHO — Essential medicines list updated to include key cancer and diabetes treatments (5 Sep 2025)
Each point above is reproduced because it has a practical consequence for Afatinib Dimaleate 40mg Tablets: the strength you can register, the pack you can release, or the wording permitted on the label. Your national prescribing information always takes precedence.
Supply & Specification Data for Afatinib Dimaleate 40mg Tablets
| Product Name | Afatinib Dimaleate Tablets (Afatinib Dimaleate 40mg Oral Tablets) |
| Specification | Each tablet contains: Afatinib Dimaleate equivalent to Afatinib 40mg |
| Dosage Form | Oral Film-Coated Tablet (for oral administration) |
| Active Ingredient | Afatinib (as Afatinib Dimaleate) |
| Pharmacological Class | Irreversible Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (Targeted Cancer Therapy) |
| Route of Administration | Oral administration (swallowed whole with water). Take once daily, at approximately the same time each day, on an empty stomach (at least 1 hour before or 3 hours after a meal). |
| Storage | Store below 25°C, in a dry place, protected from light and moisture. Keep container tightly closed. Do not freeze. |
| Therapeutic group | Oncology — Oncology |
| Manufacturer | Sinophare Bio-technology Co., Ltd. (GMP, China) |
| Documentation supplied | COA, HPLC/GC data, stability data, dossier package |
The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: Erlotinib Hydrochloride 150mg Tablets, Gefitinib Tablets 250mg, Sunitinib Malate 12.5mg Capsules, Pemetrexed Disodium Injection 100mg, Paclitaxel Albumin-Bound 100mg/20mL.
Testing, Monographs & Batch Documentation
Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.
Release testing for Afatinib Dimaleate 40mg Tablets follows the monograph you nominate — USP, EP, BP or CP. If the presentation is not covered by a monograph, the specification is frozen in writing with your quality team before the batch is manufactured.
Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.
The batch record for this product normally includes:
- Testing for assay of the active substance
- Testing for related substances and impurities
- Testing for dissolution or release profile (solid oral forms)
- Testing for uniformity of dosage units
- Testing for water content and pH where applicable
- Testing for sterility and bacterial endotoxins (parenterals and ophthalmics)
COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.
Pack Configuration, Artwork & Shipping Documents
- Pack size: Blister pack (PVC-Alu) or HDPE bottle, typically 28 or 30 tablets per blister pack or bottle. Non-standard pack sizes can be quoted against your artwork.
- Storage: Store below 25°C, in a dry place, protected from light and moisture. Keep container tightly closed. Do not freeze..
- Shelf life: 36 months (unopened). Stability data for the marketed pack is included in the dossier.
- Labelling: we typeset the carton and leaflet in English, Arabic, French, Russian and Spanish and in any further language your market requires, carrying your own brand where the local rules allow.
- Export: commercial invoice, packing list, certificate of origin, GMP certificate, COA and the free-sale certificate issued by the country of manufacture whenever your customs or regulator asks for it.
Dossier, Authority Filings & Tender Documentation
The legal manufacturer named on every document for Afatinib Dimaleate 40mg Tablets is Sinophare Bio-technology Co., Ltd., DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. The same entity appears on the GMP certificate and on the dossier submitted to your regulator.
- Site Master File and GMP certificate for the manufacturing workshops.
- Method validation, stability protocol and the shelf-life justification for the marketed pack.
- Answers to authority questions during assessment, handled by the regulatory contact who prepared the file.
- Tender and framework documentation, including pre-qualification questionnaires and sample logistics.
- Artwork and mock-up approval pack, showing the carton, label and leaflet exactly as they will be printed for your market.
Afatinib Dimaleate 40mg Tablets is presented here against cancer medicines reviewed for the WHO Model List. Inclusion in an essential-medicines list does not authorise sale in any particular country — the marketing authorisation for that market is a separate step.
Buyer Questions about Afatinib Dimaleate 40mg Tablets
What pack size is available for Afatinib Dimaleate 40mg Tablets?
Standard commercial packaging for this line is Blister pack (PVC-Alu) or HDPE bottle, typically 28 or 30 tablets per blister pack or bottle. Alternative pack sizes are produced to your specification and are supported by the corresponding stability data.
What documentation comes with a shipment of Afatinib Dimaleate 40mg Tablets?
The documentation set for every shipment includes the certificate of analysis (description, identification, assay, related substances), stability data for the marketed pack, and the site GMP certificate. Shelf life: 36 months.
Does the batch documentation for Afatinib Dimaleate 40mg Tablets support a registration filing?
The documentation set for every shipment includes the certificate of analysis (description, identification, assay, related substances), stability data for the marketed pack, and the site GMP certificate. Shelf life: 36 months. The full CTD dossier and the authority assessment file are supplied as part of a registration order; routine shipments carry the COA and stability data only.
Do you supply albumin-bound paclitaxel?
Yes — albumin-bound paclitaxel 100 mg/20 mL, supplied with assay, impurity and sterility documentation on the batch COA.
What documentation comes with an oncology order?
Batch COA including the full impurity profile and sterility results, stability data, DMF and dossier packages, plus registration support documents.
Other Oncology Products in This Range
- Erlotinib Hydrochloride 150mg Tablets — 150mg
- Gefitinib Tablets 250mg — 250mg
- Sunitinib Malate 12.5mg Capsules — 12.5mg
- Pemetrexed Disodium Injection 100mg — 100mg
- Paclitaxel Albumin-Bound 100mg/20mL — 100mg
Browse the full Oncology range; all Tablets; the complete product catalogue.
Request a Quotation for Afatinib Dimaleate 40mg Tablets
Tell us the monograph, pack size and quantity required for Afatinib Dimaleate 40mg Tablets 40mg, together with the destination market, and the quotation will state lead time and the documents that ship with the batch. Samples for registration can be added to the same order.
Sources & Regulatory Notes
- WHO EML Expert Committee — Non-small cell lung cancer review
- WHO — Essential medicines list updated to include key cancer and diabetes treatments (5 Sep 2025)
Reference information only. The published guidance summarised on this page is quoted for professional and regulatory-context purposes and does not constitute medical advice, a prescribing recommendation or a promotion of any product for a particular indication. Prescribing decisions must follow the approved product information and national treatment guidelines in the market of use.
